ArticleFrontiers in medicine2026
Rapid laboratory identification of fibrinogen Longmont: a case report and literature review.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports a case of a patient with unstable angina with abnormally low fibrinogen (FIB) levels detected during preoperative screening, yet whose clinical manifestations were markedly inconsistent with the test results. Through comparative analysis of multiple methodologies, coagulation curve analysis, manual control, and normal plasma mixing tests, it was found that the optical FIB assay yielded falsely low or failed results (<0.35 g/L), while the magnetic bead assay gave normal results (4.18 g/L; reference range 2-4 g/L) in this case, demonstrating a marked methodological discrepancy. However, as demonstrated in the literature, FIB Longmont may cause method-, reagent-, platform-, and algorithm-dependent discrepancies, with optical signal loss being a major but not exclusive mechanism combined with genetic testing, the diagnosis was ultimately confirmed as a rare dysfibrinogenemia-fibrinogen Longmont. This study aims to explore the laboratory diagnostic characteristics and differential diagnostic approaches for this condition, providing a reference for accurate interpretation of coagulation reports and avoiding misdiagnosis and mistreatment in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.